Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLexeo Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

Lexeo Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 24, 2026Townsend Richard NolanChief Executive Officer145,500Stock Option (right to buy)$592.2KGrant / award
Sep 24, 2026Otero Jose ManuelChief Operating Officer54,750Stock Option (right to buy)$222.8KGrant / award
Sep 24, 2026Tamayo Louis EdwardChief Financial Officer54,750Stock Option (right to buy)$222.8KGrant / award
Sep 24, 2026Bhalla Narinder PalChief Medical Officer54,750Stock Option (right to buy)$222.8KGrant / award
Sep 14, 2026Townsend Richard NolanChief Executive Officer2,306Common Stock$9.8KGrant / award
Sep 14, 2026Otero Jose ManuelChief Operating Officer2,110Common Stock$9KGrant / award
Sep 14, 2026Bhalla Narinder PalChief Medical Officer2,714Common Stock$11.5KGrant / award
Aug 18, 2026Townsend Richard NolanChief Executive Officer3,345Common Stock$16.2KSell
Aug 18, 2026Otero Jose ManuelChief Operating Officer1,304Common Stock$6.3KSell
Aug 18, 2026Tamayo Louis EdwardChief Financial Officer4,117Common Stock$19.9KSell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$4.07Close · Sep 22, 2026